New Discoveries and Honors in Cancer Research

Read the latest cancer research and recognition from the members of the Damon Runyon scientific circle.
October 15, 2018
Damon Runyon alumni elected to the National Academy of Medicine

Two Damon Runyon alumni were elected to the National Academy of Medicine. Election to the Academy is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.

Azad Bonni, MD, PhD (Damon Runyon Fellow ’96-‘97) at the Washington University School of Medicine, St. Louis, was recognized for discovering fundamental signaling networks governing brain development and how deregulation of these circuits contributes to cognitive disorders.

Matthew L. Meyerson, MD, PhD (Damon Runyon Fellow ’95-‘98) of Harvard Medical School and the Dana- Farber Cancer Institute, Boston, was recognized for the discovery of epidermal growth factor receptor (EGFR) mutations in lung cancer. His research showed that these mutations predict responsiveness to EGFR inhibitors and helped establish the current paradigm of precision cancer therapy.